株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

BRIC諸国の人工心臓弁市場:2012年

BRIC Markets for Heart Valve Devices 2012

発行 Decision Resources Group - Medtech Solutions 商品コード 235262
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
BRIC諸国の人工心臓弁市場:2012年 BRIC Markets for Heart Valve Devices 2012
出版日: 2012年03月30日 ページ情報: 英文
概要

当レポートでは、ブラジル・ロシア・インド・中国における人工心臓弁の市場について調査分析し、各国市場の背景、心臓弁置換・修復手術の種類と概要、人工心臓弁および修復用移植片の種類と分類、手術件数の推移と予測(〜2016年:国・部位・製品タイプ別)、人工弁および移植片の市場規模実績・予測(〜2016年:国・製品タイプ別)、主要企業と市場シェア(2011年:国別)などをまとめ、概略以下の構成でお届けいたします。

エグゼクティブサマリー

第1章 臨床環境

  • 背景
  • 診断・紹介パターン
    • 心臓弁手術
    • 経カテーテル心臓弁手術
  • 手術概要
    • 人工心臓弁手術
      • 心臓弁置換
        • 心臓弁置換外科手術
        • 経カテーテル大動脈弁置換
      • 心臓弁修復
        • 心臓弁修復手術
        • 経カテーテル僧帽弁修復
    • 競合する治療法
      • 心臓弁膜症医療管理
      • バルーン弁形成術
      • 大動脈弁バイパス
  • 臨床ガイドライン
  • 償還ガイドライン
  • 国別概要
    • ブラジル
    • ロシア
    • インド
    • 中国
      • 人口動態・経済
      • 医療制度
      • 規制環境
      • 製造・流通

第2章 製品

  • 概要
    • 調査対象製品
    • 機能区分
  • 置換用人工心臓弁
    • 機能
      • 置換手術用人工心臓弁
        • 生体弁
        • 機械弁
      • 経カテーテル置換用人工大動脈弁
    • 機能区分
    • 新しい製品
  • 心臓弁修復用デバイス
    • 機能
      • 人工弁輪
      • 経カテーテル僧帽弁修復デバイス
    • 新しい製品

第3章 臨床試験

  • 完了済み臨床試験
  • 継続中の臨床試験

第4章 ブランド・競合分析

  • 概要
    • 競合概要
    • 詳細な競合環境
    • 市場のリーダー
    • 近年のイベント
  • 置換用人工心臓弁市場
    • 競合概要
    • 詳細な競合環境
    • 市場シェア
  • 心臓弁修復用デバイス市場
    • 競合概要
    • 詳細な競合環境
      • 人工弁輪市場
      • 経カテーテル僧帽弁修復用デバイス市場

第5章 市場の展望

  • 概要
  • 置換用人工心臓弁市場
    • 市場概要
    • 詳細市場概要
      • 置換手術用人工心臓弁市場
        • 生体弁市場
        • 機械弁市場
      • 経カテーテル置換術用人工大動脈弁市場
  • 心臓弁修復用デバイス市場
    • 市場概要
    • 詳細な市場概要
      • 人工弁輪市場
      • 経カテーテル僧帽弁修復用デバイス市場

付録

図表

目次
Product Code: RPBC12HV12

Abstract

The Brazilian, Russian, Indian, and Chinese (BRIC) heart valve device market - comprising sales of heart valve replacement (mechanical, tissue, and transcatheter aortic valve replacement [TAVR]) and heart valve repair (annuloplasty) devices - was valued at nearly $180 million in 2011 and will expand through 2016, driven primarily by rising heart valve procedure volumes. Rapid economic growth and an aging population, which are increasing both the prevalence of valvular heart disease and patients' ability to pay for treatment, constitute the primary drivers of growth in the BRIC heart valve device market. The patient population will also expand as government funding for health care infrastructure improves the accessibility and affordability of the procedures for patients across all BRIC nations. Rising penetration of tissue heart valves will contribute further to market growth due to the premium price of these devices compared to mechanical heart valves. Market growth will, however, be offset by continued price erosion for all device types across all BRIC countries due to price competition between manufacturers, high-volume and bundling discounts, and government reforms that will place further budget constraints on health care facilities. Nevertheless, the BRIC heart valve device market will expand robustly over the forecast period.

Companies mentioned in this report:

Companies

  • Abbott Vascular
  • ATS Medical (acquired by Medtronic)
  • Bai Ren Medical
  • Boston Scientific
  • Braile Biomedica
  • CardiAQ Valve Technologies
  • Cardiac Dimensions
  • CryoLife
  • Direct Flow Medical
  • Edwards Lifesciences
  • Endovalve
  • Guided Delivery Systems
  • Heart Leaflet Technologies
  • HP Bioproteses
  • JenaValve Technology
  • Karboniks
  • Labcor Laboratorios
  • Lanzhou Lanfei Medical Instrument
  • Lepu Medical Technology
  • Mardil Medical
  • Medtronic
  • MiCardia
  • Mitralign
  • MedEng
  • NeoChord
  • On-X Life Technologies
  • QuantumCor
  • Roscardioinvest
  • Sadra Medical (acquired by Boston Scientific)
  • Sorin Group
  • St. Jude Medical
  • Symetis
  • TTK Healthcare
  • ValveXchange

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1 CLINICAL LANDSCAPE

  • 1.1 Background
    • 1.1.1 Introduction
    • 1.1.2 Heart Valve Disease
  • 1.2 Diagnosis and Referral Patterns
    • 1.2.1 Surgical Heart Valve Procedures
    • 1.2.2 Transcatheter Heart Valve Procedures
  • 1.3 Procedure Overview
    • 1.3.1 Heart Valve Device Procedures
      • 1.3.1.1 Heart Valve Replacement
        • 1.3.1.1.1 Surgical Heart Valve Replacement
        • 1.3.1.1.2 Transcatheter Aortic Valve Replacement
      • 1.3.1.2 Heart Valve Repair
        • 1.3.1.2.1 Surgical Heart Valve Repair
        • 1.3.1.2.2 Transcatheter Mitral Valve Repair
    • 1.3.2 Competing Treatments
      • 1.3.2.1 Heart Valve Disease Medical Management
      • 1.3.2.2 Balloon Valvuloplasty
      • 1.3.2.3 Aortic Valve Bypass
  • 1.4 Clinical Guidelines
  • 1.5 Reimbursement Guidelines
  • 1.6 Country Overviews
    • 1.6.1 Brazil
      • 1.6.1.1 Demographics and Economy
      • 1.6.1.2 Health Care System
      • 1.6.1.3 Regulatory Environment
      • 1.6.1.4 Manufacturing and Distribution
    • 1.6.2 Russia
      • 1.6.2.1 Demographics and Economy
      • 1.6.2.2 Health Care System
      • 1.6.2.3 Regulatory Environment
      • 1.6.2.4 Manufacturing and Distribution
    • 1.6.3 India
      • 1.6.3.1 Demographics and Economy
      • 1.6.3.2 Health Care System
      • 1.6.3.3 Regulatory Environment
      • 1.6.3.4 Manufacturing and Distribution
    • 1.6.4 China
      • 1.6.4.1 Demographics and Economy
      • 1.6.4.2 Health Care System
      • 1.6.4.3 Regulatory Environment
      • 1.6.4.4 Manufacturing and Distribution

2 PRODUCTS

  • 2.1 Overview
    • 2.1.1 Products Covered
    • 2.1.2 Differentiating Features
  • 2.2 Heart Valve Replacement Devices
    • 2.2.1 Functions
      • 2.2.1.1 Surgical Heart Valve Replacement Devices
        • 2.2.1.1.1 Tissue Heart Valves
        • 2.2.1.1.2 Mechanical Heart Valves
      • 2.2.1.2 Transcatheter Aortic Valve Replacement Devices
    • 2.2.2 Differentiating Features
    • 2.2.3 Emerging Products
  • 2.3 Heart Valve Repair Devices
    • 2.3.1 Functions
      • 2.3.1.1 Annuloplasty Devices
      • 2.3.1.2 Transcatheter Mitral Valve Repair Devices
    • 2.3.2 Emerging Products

3 CLINICAL TRIALS

  • 3.1 Completed Clinical Trials
  • 3.2 Ongoing Clinical Trials

4 BRANDS AND COMPETITIVE ANALYSIS

  • 4.1 Overview
    • 4.1.1 Competitive Snapshot
    • 4.1.2 Detailed Competitive Landscape
    • 4.1.3 Market Leaders
    • 4.1.4 Recent Events
  • 4.2 Heart Valve Replacement Device Market
    • 4.2.1 Competitive Snapshot
    • 4.2.2 Detailed Competitive Landscape
      • 4.2.2.1 Surgical Heart Valve Replacement Device Market
        • 4.2.2.1.1 Tissue Heart Valve Market
        • 4.2.2.1.2 Mechanical Heart Valve Market
    • 4.2.2.2 Transcatheter Aortic Valve Replacement Market
    • 4.2.3 Market Shares
  • 4.3 Heart Valve Repair Device Market
    • 4.3.1 Competitive Snapshot
    • 4.3.2 Detailed Competitive Landscape
      • 4.3.2.1 Annuloplasty Device Market
      • 4.3.2.2 Transcatheter Mitral Valve Repair Device Market

5 MARKET OUTLOOK

  • 5.1 Overview
    • 5.1.1 Market Snapshot
    • 5.1.2 Detailed Market Overview
  • 5.2 Heart Valve Replacement Device Market
    • 5.2.1 Market Snapshot
    • 5.2.2 Detailed Market Overview
      • 5.2.2.1 Surgical Heart Valve Replacement Device Market
        • 5.2.2.1.1 Tissue Heart Valve Market
        • 5.2.2.1.2 Mechanical Heart Valve Market
    • 5.2.2.2 Transcatheter Aortic Valve Replacement Device Market
  • 5.3 Heart Valve Repair Device Market
    • 5.3.1 Market Snapshot
    • 5.3.2 Detailed Market Overview
      • 5.3.2.1 Annuloplasty Device Market
      • 5.3.2.2 Transcatheter Mitral Valve Repair Device Market

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Heart Valve Device Market, by Country, BRIC (USD), 2010 - 2016
  • Table 1: Heart Valve Device Market Landscape, BRIC (USD), 2011 and 2016
  • Table 2: Heart Valve Device Market Leaders, by Country and Revenue, BRIC, 2011
  • Table 3: Most Promising Emerging Technologies in the Heart Valve Device Market, BRIC, 2011 - 2016
  • Table 4: Expected Key Events in the Heart Valve Device Market, BRIC, 2012 - 2016
  • Table 5: Factors Impacting the Heart Valve Device Market, by Product Type, BRIC, 2011 - 2016
  • Table 6: Companies Mentioned in This Report

1 CLINICAL LANDSCAPE

  • Figure 2: Treatment Providers and Referral Patterns
  • Table 7: Treatment Providers and Referral Patterns, by Treatment Phase
  • Table 8: Heart Valve Device Procedures
  • Table 9: Competing Treatments
  • Table 10: Heart Valve Procedure Reimbursement Guidelines, by Country, BRIC
  • Table 11: Key Health and Economic Indicators, Brazil
  • Table 12: Key Health and Economic Indicators, Russia
  • Table 13: Key Health and Economic Indicators, India
  • Table 14: Key Health and Economic Indicators, China

2 PRODUCTS

  • Table 15: Heart Valve Device Market, by Product Type, BRIC
  • Figure 3: Recommendations for Heart Valve Devices, by Age Group
  • Table 16: Advantages and Disadvantages of Heart Valve Devices, by Product Type
  • Table 17: Heart Valve Replacement Device Functions, by Technique
  • Table 18: Tissue Heart Valve Functions, by Material and Product Feature
  • Table 19: Advantages and Disadvantages of Surgical Heart Valve Replacement Devices, by Product Type
  • Table 20: Advantages and Disadvantages of Tissue Heart Valves, by Material
  • Table 21: Advantages and Disadvantages of Xenograft Tissue Heart Valves, by Product Feature
  • Table 22: Advantages and Disadvantages of Stented Tissue Heart Valves, by Design
  • Table 23: Advantages and Disadvantages of Xenograft Tissue Heart Valves, by Material
  • Table 24: Emerging Products in Development for the Surgical Heart Valve Replacement Device Market, BRIC, 2011 - 2016
  • Table 25: Emerging Products in Development for the TAVR Device Market, BRIC, 2011 - 2016
  • Table 26: Heart Valve Repair Device Functions, by Technique
  • Table 27: Emerging Products in Development for the TMVR Device Market, BRIC, 2011 - 2016

3 CLINICAL TRIALS

  • Table 28: Summary of Porcine Tissue Valve Long-Term Durability Trial
  • Table 29: Summary of Pericardial Tissue Valve Long-Term Durability Trial
  • Table 30: Summary of Mitral Valve Repair versus Mitral Valve Replacement Trial
  • Table 31: Summary of Mitral Valve Repair Long-Term Safety and Efficacy Trial
  • Table 32: Summary of Medtronic CoreValve REDO Study
  • Table 33: Summary of PARTNER Trial
  • Table 34: Summary of PARTNER II Trial
  • Table 35: Summary of Medtronic CoreValve U.S. Pivotal Trial
  • Table 36: Summary of FRANCE 2 Study
  • Table 37: Summary of EVEREST II Study
  • Table 38: Summary of TRITON trial
  • Table 39: Summary of Randomized On-X Anticoagulation Trial

4 BRANDS AND COMPETITIVE ANALYSIS

  • Table 40: Heart Valve Device Market Leaders, by Country and Revenue, BRIC, 2011
  • Table 41: Recent Events in the Heart Valve Device Market, BRIC
  • Table 42: Leading Competitors in the Tissue Heart Valve Market, by Unit Sales, as a % of Total, Brazil, 2011
  • Table 43: Leading Competitors in the Mechanical Heart Valve Market, by Unit Sales, as a % of Total, Russia, 2011
  • Table 44: Leading Competitors in the Mechanical Heart Valve Market, by Unit Sales, as a % of Total, India, 2011
  • Table 45: Leading Competitors in the Mechanical Heart Valve Market, by Unit Sales, as a % of Total, China, 2011

5 MARKET OUTLOOK

  • Figure 4: Heart Valve Device Market, by Product Type, BRIC (USD), 2010 - 2016
  • Figure 5: Heart Valve Device Market, by Country, BRIC (USD), 2010 - 2016
  • Table 46: Factors Impacting the Heart Valve Device Market, by Product Type, BRIC, 2011 - 2016
  • Table 47: Heart Valve Device Procedures, by Country, BRIC, 2010 - 2016
  • Table 48: Heart Valve Device Procedures, by Product Type, BRIC, 2010 - 2016
  • Table 49: Heart Valve Device Market, by Country, BRIC (USD), 2010 - 2016
  • Table 50: Heart Valve Device Market, by Product Type, BRIC (USD), 2010 - 2016
  • Figure 6: Heart Valve Replacement Device Market, by Country, BRIC (USD), 2010 - 2016
  • Figure 7: Heart Valve Replacement Device Market, by Product Type, BRIC (USD), 2010 - 2016
  • Table 51: Heart Valve Replacement Procedures, by Country, BRIC, 2010 - 2016
  • Table 52: Heart Valve Replacement Procedures, by Technique, BRIC, 2010 - 2016
  • Table 53: Heart Valve Replacement Procedures, by Position, BRIC, 2010 - 2016
  • Table 54: Heart Valve Replacement Procedures, by Position, Brazil, 2010 - 2016
  • Table 55: Heart Valve Replacement Procedures, by Position, Russia, 2010 - 2016
  • Table 56: Heart Valve Replacement Procedures, by Position, India, 2010 - 2016
  • Table 57: Heart Valve Replacement Procedures, by Position, China, 2010 - 2016
  • Table 58: Aortic Heart Valve Replacement Procedures, by Product Type, BRIC, 2010 - 2016
  • Table 59: Mitral Heart Valve Replacement Procedures, by Product Type, BRIC, 2010 - 2016
  • Table 60: Other Heart Valve Replacement Procedures, by Product Type, BRIC, 2010 - 2016
  • Table 61: Heart Valve Replacement Device Market, by Country, BRIC (USD), 2010 - 2016
  • Table 62: Heart Valve Replacement Device Market, by Technique, BRIC (USD), 2010 - 2016
  • Table 63: Surgical Heart Valve Replacement Procedures, by Country, BRIC, 2010 - 2016
  • Table 64: Surgical Heart Valve Replacement Procedures, by Product Type, BRIC, 2010 - 2016
  • Table 65: Surgical Heart Valve Replacement Device Market, by Country, BRIC (USD), 2010 - 2016
  • Table 66: Surgical Heart Valve Replacement Device Market, by Product Type, BRIC (USD), 2010 - 2016
  • Table 67: Tissue Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 68: Tissue Heart Valve Procedures, by Material, BRIC, 2010 - 2016
  • Table 69: Xenograft Tissue Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 70: Xenograft Tissue Heart Valve Procedures, by Position, BRIC, 2010 - 2016
  • Table 71: Aortic Xenograft Tissue Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 72: Mitral Xenograft Tissue Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 73: Other Xenograft Tissue Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 74: Xenograft Tissue Heart Valve Market, by Country, BRIC (USD), 2010 - 2016
  • Table 75: Xenograft Tissue Heart Valve Market, Brazil (USD and BRL), 2010 - 2016
  • Table 76: Xenograft Tissue Heart Valve Market, Russia (USD and RUB), 2010 - 2016
  • Table 77: Xenograft Tissue Heart Valve Market, India (USD and INR), 2010 - 2016
  • Table 78: Xenograft Tissue Heart Valve Market, China (USD and CNY), 2010 - 2016
  • Table 79: Mechanical Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 80: Mechanical Heart Valve Procedures, by Position, BRIC, 2010 - 2016
  • Table 81: Aortic Mechanical Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 82: Mitral Mechanical Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 83: Other Mechanical Heart Valve Procedures, by Country, BRIC, 2010 - 2016
  • Table 84: Mechanical Heart Valve Market, by Country, BRIC (USD), 2010 - 2016
  • Table 85: Mechanical Heart Valve Market, Brazil (USD and BRL), 2010 - 2016
  • Table 86: Mechanical Heart Valve Market, Russia (USD and RUB), 2010 - 2016
  • Table 87: Mechanical Heart Valve Market, India (USD and INR), 2010 - 2016
  • Table 88: Mechanical Heart Valve Market, China (USD and CNY), 2010 - 2016
  • Table 89: TAVR Device Market, BRIC (USD), 2010 - 2016
  • Figure 8: Heart Valve Repair Device Market, by Country, BRIC (USD), 2010 - 2016
  • Figure 9: Heart Valve Repair Device Market, by Country, as a % of Total, BRIC, 2011 and 2016
  • Table 90: Heart Valve Repair Procedures, by Country, BRIC, 2010 - 2016
  • Table 91: Heart Valve Repair Device Market, by Country, BRIC (USD), 2010 - 2016
  • Table 92: Annuloplasty Device Market, Brazil (USD and BRL), 2010 - 2016
  • Table 93: Annuloplasty Device Market, Russia (USD and RUB), 2010 - 2016
  • Table 94: Annuloplasty Device Market, India (USD and INR), 2010 - 2016
  • Table 95: Annuloplasty Device Market, China (USD and CNY), 2010 - 2016

APPENDIX: METHODOLOGY

  • Table 96: Average Currency Exchange Rates

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 97: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Back to Top